Triclosan

Dermatitis

Volumn 17, Issue 4, 2006, Pages 204-207

  Campbell, Lauren ^a   Zirwas, Matthew J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCIDE; CHLORHEXIDINE; CIPROFLOXACIN; IRGASAN CH 3565; METICILLIN; TRICLOSAN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ATOPIC DERMATITIS; CARCINOGENICITY; CONTACT DERMATITIS; ESCHERICHIA COLI; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RISK BENEFIT ANALYSIS;

ANTI-INFECTIVE AGENTS, LOCAL; DERMATITIS, CONTACT; HUMANS; TRICLOSAN;

EID: 33846550586     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.2310/6620.2006.06014     Document Type: Review

References (51)

1. Fraise AP. Biocide abuse and antimicrobial resistance-a cause for concern? J Antimicrob Chemother 2002;49:11-2.
2. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998;394:531-2.
3. Sivaraman S, Zwahlen J, Bell AF. Structure-activity studies of inhibition of Fabl, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant Fabls. Biochemistry 2003;42: 4406-13.
4. Levy CW, Roujeinikovai A, Sedelnikova S, et al. Molecular basis of triclosan activity. Nature 1999;398:383-4.
5. Vischer WA, Regos J. Antimicrobial spectrum of triclosan, a broad spectrum antimicrobial agent. Zentralbl Bakteriol Mikrobiol Hyg 1974;226:376-89.
6. Tierno PM. Efficacy of triclosan. Am J Infect Control 1999;27:71-2.
7. Winnefeld M, Richard MA, Drancourt M. Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use. Br J Dermatol 2000;143:546-50.
8. Loeb MB, Craven S, McGreer AJ, et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Fpidemiol 2003;157:40-7.
9. Faoagali JL, George N, Fong J, et al. Comparison of the antibacterial efficacy of 4% chlorhexidine gluconate and 1% triclosan hand-wash products in an acute clinical ward. Am J Infect Control 1999;27: 320-6.
10. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin- resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994;30: 59-64.
11. Zafar AB, Butler RC, Reese DJ, et al. Use of 0.3% triclosan (BactiStat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995;23:200-8.
12. Webster J. Handwashing in neonatal intensive care nursery: product acceptability and effectiveness of chlorhexidine gluconate 4% and triclosan 1%. J Hosp Infect 1992;21:137-41.
13. Brady LM, Thomson M, Palmer MA, Harkness JL. Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 1990;152:240-5.
14. Newsom SW, Rowland C. Studies on perioperative skin flora. J Hosp Infect 1988;11 Suppl B:21-6.
15. Huang Y, Oie S, Kamiya A. Comparative effectiveness of hand-cleansing agents for removing methicillin-resistant Staphylococcus aureus from experimentally contaminated fingertips. Am J Infect Control 1994;22:224-7.
16. Barry MA, Craven DE, Goularte TA, Lichtenberg DA. Serratia marcescens contamination of antiseptic soap containing triclosan: implications for nosocomial infection. Infect Control 1984;5:427-30.
17. Kampf G, Wischnewski N, Schulgen G, et al. Prevalence and risk factors for nosocomial lower respiratory tract infections in German hospitals. J Clin Epidemiol 1998;51:485-502.
18. Jones RD, Jampani HB, Newman JL, Lee AS. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 2000;28:184-96.
19. Breneman DL, Hanifin JM, Berge CA, et al. The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis. Cutis 2000;66:296-300.
20. Tan L, Nielsen NH, Young DC. Use of antimicrobial agents in consumer products. Arch Dermatol 2002;138:1082-6.
21. Levy SB. Antimicrobial consumer products: where's the benefit? What's the risk? Arch Dermatol 2002;138:1087-8.
22. Levy SB. Antibiotic and antiseptic resistance: impact on public health. Pediatr Infect Dis J 2000;19(10 Suppl):S120-2.
23. Larson EL, Lin SX, Gomez-Pichardo C. Effect of home cleansing and handwashing products on infectious disease symptoms. Ann Intern Med 2004;140:321-9.
24. Levy SB. Antibacterial household products: cause for concern. Emerg Infect Dis 2001;7(3 Suppl):512-5.
25. Slater FM. Efficacy of triclosan: reply. Am J Infect Control 1999;27: 72-3.
26. Association for Professionals in Infection Control and Epidemiology (APIC) Guidelines Committee: The use of antimicrobial household products: APIC position statement. APIC News 1997;16:13.
27. Perencevich EN, Wong MT, Harris AD. National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control 2001;29:281-3.
28. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998;166: 305-9.
29. Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. J Appl Microbiol 2002;92:65S-71S.
30. Schweizer HP. Triclosan: a widely used biocide and its links to antibiotics. FEMS Microbiol Lett 2001;202:1-7.
31. Yamamoto T, Tamura Y, Yokota T. Antiseptic and antibiotic resistance plasmid in Staphylococcus aureus that possesses ability to confer chlorhexidine and acrinol resistance. Antimicrob Agents Chemother 1988;32:932-5.
32. McMurry LM, McDermott PF, Levy SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999;43:711-3.
33. Akimitsu N, Hamamoto H, Inoue R, et al. Increase in resistance of methicillin-resistant Staphylococcus aureus to B-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999;43:3042-3.
34. Chuanchuen R, Beinlich K, Hoang TT, et al. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multi-drug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001;45:428-32.
35. McBain AJ, Ledder RG, Sreenivasan P, et al. Selection for high-level resistance by chronic triclosan exposure is not universal. J Antimicrob Chemother 2004;53:772-7.
36. Aiello AE, Marshall B, Levy SB, et al. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 2004;48:2973-9.
37. Wong CS, Beck MH. Allergic contact dermatitis from triclosan in antibacterial handwashes. Contact Dermatitis 2001;45:307.
38. Storer E, Koh KJ, Warren L. Severe contact dermatitis as a result of an antiseptic bath oil. Australas J Dermatol 2004;45:73-5.
39. Lachapelle JM, Tennstedt D. Low allergenicity of triclosan. Predictive testing in guinea pigs and in humans. Dermatologica 1979;158:379-83.
40. Wahlberg JE. Routine patch testing with Irgasan DP 300. Contact Dermatitis 1976;2:292.
41. Loo WJ. Irritant dermatitis due to prolonged contact with Oilatum Plus. Br J Dermatol 2003;148:171-2.
42. Perrenoud D, Bircher A, Hunziker T, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis 1994;30: 276-9.
43. Steinkjer B, Braathen LR. Contact dermatitis from triclosan. Contact Dermatitis 1988;18:243-4.
44. Veronesi S, de Padova MP, Vanni D, Melino M. Contact dermatitis to triclosan. Contact Dermatitis 1986;15:257-8.
45. Zaugg T, Hunziker T. Germall III and triclosan. Contact Dermatitis 1987;17:262.
46. Larson EL, Butz AM, Gullette DL, Laughon BA. Alcohol for surgical scrubbing? Infect Control Hosp Epidemiol 1990;11:139-43.
47. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 2004;17:863-93.
48. Nettis E, Colanardi MC, Soccio AL, et al. Occupational irritant and allergic contact dermatitis among healthcare workers. Contact Dermatitis 2002;46:101-7.
49. Kanerva L, Jolanki R, Estlander T. Occupational allergic contact dermatitis from benzalkonium chloride. Contact Dermatitis 2000; 42:357-8.
50. Rule KL, Ebbett VR, Vikesland PJ. Formation of chloroform and chlorinated organics by free-chlorine-mediated oxidation of triclosan. Environ Sci Technol 2005;39:3176-85.
51. Regös J, Zak O, Solf R, et al. Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. Dermatologica 1979;158:72-9.